Total Funding
51
61
Total FundingSeries B raised
Growth Score
-2 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
29854
Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.
- Sharif Tabebordbar: Co-Founder and Chief Scientific Officer
- Mark Fielden: Co-Founder, Senior Vice President of Nonclinical Development
About the Company
Kate Therapeutics is a biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies targeting genetically defined muscle and heart diseases. The company utilizes innovative technology platforms to improve tissue-specific delivery and gene regulation, addressing key limitations of existing gene therapies.
